Jeff Geschwind, MD: Innovator in Cancer Drugs Founder of Cage Pharma, Jeff Geschwind, MD, researches tumor metabolism-targeting drugs, particularly glycolysis inhibitors. His work opens new avenues for treating aggressive cancers through innovative pharmaceutical approaches. https://www.eurekalert.org/multimedia/645474